secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001396814-23-000013
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira BioSciences announces director Yvonne Greenstreet to retire from board
-----------------------------------------------------------------------------

- Yvonne Greenstreet, independent director for 9 years, retiring effective March 31, 2023.
- Greenstreet is CEO of Alnylam Pharmaceuticals; retirement not due to any disagreement.
- Pacira will initiate search for an independent board member to replace her.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000013/0001396814-23-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681423000013/pcrx-20230318.htm
  HTML page:      https://secwatch.observer/filing/0001396814-23-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer